Egyptian Drug Authority Clears Chinese Sinopharm Vaccine for Emergency Use


The Egyptian Drug Authority has cleared Sinopharm's COVID-19 vaccine for emergency use, Health Minister Hala Zayed said in a televised phone call.

The approval was granted after the authority had carried out four phases of examinations, with all results unequivocally proving it is safe to use the Chinese vaccine, she added.

The minister also said that AstraZeneca will start supplying Egypt with its COVID-19 vaccine doses in the third or fourth week of this month, as negotiations between the company and Egyptian authorities have reached an advanced stage.

Zayed said that Egypt has secured 20 million doses of AstraZeneca's COVID-19 vaccine.

In total, Egypt secured 100 million doses, 40 million of which are from Sinopharm, 20 million from AstraZeneca and 40 million from the Global Alliance for Vaccines and Immunization (GAVI), according to Zayed.

The minister said that Egypt’s Vacsera is currently in talks to locally manufacture coronavirus vaccines.